Intech Investment Management LLC raised its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 14.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 459,901 shares of the company’s stock after acquiring an additional 56,308 shares during the quarter. Intech Investment Management LLC owned approximately 0.06% of Colgate-Palmolive worth $39,239,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in CL. State Street Corp raised its holdings in Colgate-Palmolive by 97.4% in the 2nd quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after purchasing an additional 46,476,510 shares during the period. Bank of New York Mellon Corp grew its holdings in Colgate-Palmolive by 8.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after buying an additional 1,010,872 shares in the last quarter. First Eagle Investment Management LLC grew its stake in Colgate-Palmolive by 1.1% during the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after acquiring an additional 88,917 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Colgate-Palmolive by 17.4% in the first quarter. Bank of America Corp DE now owns 6,637,597 shares of the company’s stock worth $565,722,000 after purchasing an additional 986,063 shares during the last quarter. Finally, Amundi increased its stake in Colgate-Palmolive by 19.9% in the 2nd quarter. Amundi now owns 6,218,257 shares of the company’s stock worth $570,090,000 after acquiring an additional 1,033,918 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock opened at $99.62 on Monday. The company has a 50 day moving average price of $90.94 and a 200-day moving average price of $90.29. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. Colgate-Palmolive Company has a fifty-two week low of $75.96 and a fifty-two week high of $101.18. The company has a market capitalization of $79.19 billion, a PE ratio of 39.07, a P/E/G ratio of 4.51 and a beta of 0.31.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.34 billion. During the same quarter in the previous year, the business earned $0.91 earnings per share. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.92 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th were paid a dividend of $0.53 per share. The ex-dividend date was Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 83.14%.
Insider Buying and Selling
In other news, insider John Hazlin sold 23,376 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total value of $2,317,730.40. Following the transaction, the insider owned 27,021 shares of the company’s stock, valued at $2,679,132.15. The trade was a 46.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Noel R. Wallace sold 20,000 shares of Colgate-Palmolive stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $100.26, for a total transaction of $2,005,200.00. Following the completion of the transaction, the chief executive officer directly owned 359,700 shares in the company, valued at $36,063,522. This represents a 5.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 77,414 shares of company stock worth $7,613,786 over the last quarter. Insiders own 0.43% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. UBS Group upped their target price on shares of Colgate-Palmolive from $106.00 to $112.00 and gave the company a “buy” rating in a research report on Monday, November 2nd. Barclays lifted their target price on Colgate-Palmolive from $87.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 3rd. Jefferies Financial Group reissued a “hold” rating and set a $89.00 target price (up from $88.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating on the stock in a report on Monday, November 2nd. Finally, Weiss Ratings cut shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.22.
Trending Headlines about Colgate-Palmolive
Here are a few of the latest headlines about CL:
- Positive Sentiment: A valuation analysis argues that Colgate-Palmolive shares may be about 21% below fair value, which could support investor interest if the estimate proves accurate. Colgate Palmolive (CL) Stock May Be 21% Below Fair Value Today
- Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85 and made smaller increases to FY2027 ($4.06) and FY2028 ($4.38) forecasts. These revisions offer a modestly constructive earnings signal, though they are one analyst’s estimates. Zacks Research earnings estimate revisions
- Neutral Sentiment: The estimate changes were mixed: Zacks raised some quarterly forecasts but lowered others, including Q1 2027 and Q1–Q2 2028. That tempers the positive full-year revisions and does not indicate a broad upgrade to near-term expectations. Zacks Research quarterly earnings estimate revisions
Colgate-Palmolive Company Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
